Top 50 Life Science Startup Investors in Spain (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Centre for the Development of Industrial Technology (CDTI)
VC Fund
|
8 | Spain, United States, France | Grant, Seed | Biotechnology, Health Care, Software | $126k–$5.9M |
|
Bullnet Capital
VC Fund
|
7 | Spain, United States, Mexico | Seed, Series A | Software, Information Technology, Manufacturing | $590k–$11M |
|
Capital Cell
VC Fund
|
6 | Spain, United States, United Kingdom | Equity Crowdfunding, Seed | Health Care, Biotechnology, Medical | $137k–$1.9M |
|
ENISA
VC Fund
|
4 | Spain, United States, France | Seed, Debt Financing, Pre-Seed | Software, Health Care, Information Technology | $66k–$2.2M |
|
Asabys Partners
VC Fund
|
4 | Spain, France, Belgium | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.2M–$55M |
|
Invivo Capital Partners
VC Fund
|
3 | Spain, France, Belgium | Seed, Series A | Biotechnology, Pharmaceutical, Health Care | $1.6M–$71M |
|
Inveready
VC Fund
|
3 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, Information Technology | $494k–$11M |
|
Xesgalicia
VC Fund
|
2 | Spain, Portugal | Seed, Pre-Seed | Software, Biotechnology, Pharmaceutical | $304k–$5.5M |
|
Monte Carlo Capital
VC Fund
|
2 | United States, United Kingdom, Switzerland | Seed, Series A | Artificial Intelligence, FinTech, Software | $375k–$100M |
|
Amadeus Capital Partners
VC Fund
|
2 | United Kingdom, United States, Spain | Series B, Seed, Series A | Software, Artificial Intelligence, Information Technology | $800k–$43M |
|
Talis Capital
VC Fund
|
2 | United Kingdom, United States, Germany | Series A, Seed, Series B | Software, Information Technology, E-Commerce | $1M–$30M |
|
Ysios Capital
VC Fund
|
2 | Spain, United States, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $2.2M–$135M |
|
CDTI Innovación's INNVIERTE program
VC Fund
|
2 | Spain, Switzerland | Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $526k–$4.2M |
|
Charme Capital Partners
VC Fund
|
2 | Spain | Series A | Genetics, Life Science, Biotechnology | $5.5M–$20M |
|
Criteria Venture Tech
VC Fund
|
2 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, E-Commerce | $256k–$21M |
|
Alta Life Sciences
VC Fund
|
2 | Spain, United States | Series A, Seed | Biotechnology, Health Care, Medical Device | $3M–$33M |
|
Clave Capital
VC Fund
|
2 | Spain, Chile, Switzerland | Seed, Series A | Biotechnology, Health Care, Software | $527k–$16M |
|
BeAble Capital
VC Fund
|
2 | Spain, Italy | Pre-Seed, Seed | Biotechnology, Manufacturing, Software | $124k–$1.2M |
|
Nara Capital
VC Fund
|
2 | Spain | Seed | Life Science, Biotechnology, Medical | $2M–$7.4M |
|
Amino Collective
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Medical | $125k–$26M |
|
Josep Carreras Leukaemia Research Institute
VC Fund
|
2 | Spain | Seed | Life Science, Biotechnology | $3.4M–$7.4M |
|
Demium Capital
VC Fund
|
2 | Spain, Portugal, Poland | Pre-Seed, Seed, Series A | Software, FinTech, Health Care | $110k–$3.1M |
|
BStartup
VC Fund
|
2 | Spain, Mexico, United States | Seed, Pre-Seed | Software, Information Technology, Artificial Intelligence | $110k–$2.2M |
|
Speedinvest
VC Fund
|
2 | Germany, United Kingdom, Austria | Seed, Series A, Pre-Seed | Software, FinTech, Financial Services | $406k–$38M |
|
BoxOne Ventures
VC Fund
|
2 | Canada, United States, United Kingdom | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Software | $274k–$41M |
|
Good Seed Ventures
VC Fund
|
1 | Germany, Israel, United States | Seed, Series A, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $25k–$21M |
|
Pontifax
VC Fund
|
1 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Pharmaceutical | $4M–$104M |
|
Gilde Healthcare
VC Fund
|
1 | United States, The Netherlands, Germany | Series B, Series C, Series A | Biotechnology, Health Care, Medical | $8.8M–$120M |
|
Kurma Partners
VC Fund
|
1 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.3M–$80M |
|
Clave Mayor
VC Fund
|
1 | Spain, Germany, United States | Seed, Series A | Software, Biotechnology, Medical | $262k–$8.9M |
|
Santander
VC Fund
|
1 | United Kingdom, Spain, United States | Debt Financing, Post-IPO Debt, Seed | Energy, Financial Services, Renewable Energy | |
|
Alantra
VC Fund
|
1 | Spain, France, Sweden | Private Equity, Debt Financing, Series B | Financial Services, Manufacturing, Information Technology | |
|
Ship2B Ventures
VC Fund
|
1 | Spain, Germany, United Kingdom | Seed, Series A | Health Care, Biotechnology, Agriculture | |
|
General Inception
VC Fund
|
1 | United States, Spain, France | Seed, Pre-Seed | Biotechnology, Life Science, Genetics | |
|
Mariliis Holm
Angel
|
1 | Spain, Iceland, United States | Pre-Seed, Angel | Food Processing, Seafood, Wellness | |
|
Grow Venture Partners
VC Fund
|
1 | Spain | Pre-Seed, Seed | Health Care, Artificial Intelligence, Biotechnology | |
|
Innova-Tech Consulting
VC Fund
|
1 | Canada, Spain | Series A, Seed, Series B | Solar, Energy, Medical | |
|
BCN PEPTIDES
VC Fund
|
1 | Spain | Medical, Biopharma, Life Science | ||
|
Inaki Berenguer
Angel
|
1 | Spain, United States, United Kingdom | Seed, Angel, Pre-Seed | Financial Services, FinTech, E-Commerce | |
|
Fides Capital
VC Fund
|
1 | Spain | Seed, Pre-Seed, Series A | Software, Automotive, Telecommunications | |
|
Ezten Venture Capital Fund
VC Fund
|
1 | Spain | Seed | Software, Automotive, Clean Energy | |
|
INNVIERTE ECONOMIA SOSTENIBLE SICC SME SA
VC Fund
|
1 | Spain | Pre-Seed, Series A | Apps, Big Data, Aerospace | |
|
Novartis Venture Fund
VC Fund
|
1 | United States, Switzerland, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Therapeutics | $4.7M–$105M |
|
John Bethell
Angel
|
1 | Spain | Debt Financing | FinTech, Medical, Life Science | |
|
Addition
VC Fund
|
1 | United States, United Kingdom, Brazil | Series A, Series B, Series C | Software, Financial Services, FinTech | |
|
GENESIS Biomed
VC Fund
|
1 | Spain | Seed, Pre-Seed | Medical, Pharmaceutical, Biopharma | |
|
SeedBlink
VC Fund
|
1 | Romania, United States, United Kingdom | Seed, Pre-Seed, Series A | Software, Information Technology, SaaS | |
|
ICF Capital
VC Fund
|
1 | Spain, United States, Mexico | Debt Financing, Seed | Software, Biotechnology, Health Care | |
|
CRB Inverbío
VC Fund
|
1 | Spain, Mexico | Series A, Seed | Medical, Health Care, Biotechnology | $2.2M–$8.9M |
|
BAGi
VC Fund
|
1 | Spain, Norway, Switzerland | Seed, Angel | Internet, Health Care, Information Technology | |
| Access all 130 investors in Spain Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Grant, Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 175
- Round size: Seed $562k–$5.9M; Grant $126k–$861k
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Xoople — Xoople operates as an earth intelligence company. Xoople powers the next generation of Earth data intelligence to achieve a systematic understanding of physical changes on the Earth’s surface.
- TetraxAI — TetraxAI helps renewable energy developers and investors automate due diligence and risk assessment - 100x faster, 10x cheaper, with full legal traceability.
- Golden Owl —
Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 60
- Round size: Seed $1M–$3.3M; Series A $590k–$11M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $47M in 2023
Portfolio highlights
- FlexiiC — FlexiiC is a deep-tech firm developing printed, flexible integrated circuits for sustainable IoT and smart packaging solutions.
- Bioherent — Photonic biosensors for drug allergy diagnosis
- Impetux Optics — IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues and cells. We are focusing the application of our technology in fields like Mechanobiology where the study of diseases directly related with cell migration or development are demanding new techniques. We offer cutting-edge non-invasive to...
Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Equity Crowdfunding, Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 49
- Round size: Seed $384k–$1.9M; Equity Crowdfunding $137k–$1.3M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
- EVis Bioscience — EVis Bioscience offers gene delivery solutions using extracellular vesicles, lipid nanoparticles, and hybrid systems.
ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Debt Financing, Pre-Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 175
- Round size: Seed $66k–$2.2M; Pre-Seed $186k–$1.2M; Debt Financing $66k–$494k
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Swipoo — Transferencia de vehículos y cambio de nombre automatizado.
- TucanPay — TucanPay is a money transfer platform that sends money between continents.
- DARWIN Biomed — Biomedical Engineering
Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 35
- Round size: Seed $1.2M–$13M; Series A $7M–$55M; Series B $19M–$55M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — raised $117M in 2022
Portfolio highlights
- Qida — Qida is a trusted company in the health and social sector that selects the best caregivers for the elderly and / or dependent.
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Health Care
- Stage:Seed, Series A
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 23
- Round size: Seed $1.6M–$11M; Series A $2.2M–$71M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $44M in 2019
Portfolio highlights
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
- Telomere Therapeutics — Telomere Therapeutics is a University of Barcelona spinoff developing telomerase gene therapy to treat pulmonary fibrosis
Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 142
- Round size: Seed $494k–$5.5M; Series A $1.6M–$11M
- Lead/follow: 52% lead, 48% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- MedUX — MedUX is the leading Customer Experience and Network monitoring solution for telecommunication services, governments, and OTT providers by using AI Powered Real-Time Applied Analytics
- VOLAVA — Volava is a fitness platform that brings the energy and benefits of studio-style workouts to the convenience and comfort of home. It is a connected, technology-enabled fitness boutique. It also makes fitness entertaining, approachable, effective, and convenient, while fostering social connections and building a community around wellness. Volavawas founded in 2017 and is headquartered in Barcelona, Spain.
- Fleksy — The Fleksy Software Keyboard Development Kit (SDK) enables companies to overcome the challenge of building a top-notch typing experience on both iOS and Android. Your company can then focus on its area of expertise & value-add for a simple monthly licensing fee.
XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.
Show more...Investment focus
- Industry: Software, Biotechnology, Pharmaceutical
- Stage:Seed, Pre-Seed
- Geography: Spain, Portugal
Investor stats
- Total investments: 30
- Round size: Seed $304k–$5.5M; Pre-Seed $439k–$2.5M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Appentra — Ensure correctness, modernization, security, and optimization for your Fortran, C, and C++ code with a powerful and efficient solution.
- Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
- Iteria Biopharma — Iteria Biopharma focused on discovering and developing precision oncology drugs, particularly first-in-class new chemical entities (NCEs) for challenging cancer targets with high unmet medical needs.
Discover Monte Carlo Capital, a leading angel investment firm supporting early-stage startups in technology.
Show more...Investment focus
- Industry: Artificial Intelligence, FinTech, Software
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 66
- Round size: Seed $375k–$10M; Series A $1.3M–$100M
- Lead/follow: 35% lead, 65% follow
Portfolio highlights
- Klay — Reimagine music with KLAY.
- Shipsi — Shipsi empowers any retailer with the ability to offer an easy “instant shipping” option on their checkout page—without worrying about logistics. They use existing infrastructure and last-mile delivery networks to help customers order now AND get it now. Shipsi was founded in 2017 and is headquartered in Austin, TX.
- Scout AI — Scout AI is building the robotic foundation model for defense.
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Series B, Seed, Series A
- Geography: United Kingdom, United States, Spain
Investor stats
- Total investments: 230
- Round size: Seed $800k–$9.2M; Series A $2.6M–$27M; Series B $6.8M–$43M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $88M in 2023
Portfolio highlights
- Tenzo — Tenzo is a restaurant analytics and AI forecasting platform for restaurants, pubs and cafes. Tenzo makes running restaurants easy with full data visibility.
- Xampla — Xampla's natural plant polymer technology is the innovative technology powering materials to change the world with plastic-free replacements and more.
- Nu Quantum — Nu Quantum has been pioneering quantum networking technology since 2018. Our market-leading expertise is uniquely positioned to deliver a distributed quantum...
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We back founders who see the future differently.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 80
- Round size: Seed $1M–$13M; Series A $3M–$24M; Series B $10M–$30M
- Lead/follow: 54% lead, 46% follow
Portfolio highlights
- Luminance — Luminance develops document analysis software to secure big data systems for multinational and governmental organizations. Its software provides overview of various companies and picks out warning signs without any instructions; and document clustering and filtering to enable users focus on eliminating administrative tasks. Luminance identifiesrisk clauses, data visualization, and anomaly detection, as well as reviews and enables users to allocate tasks and track the progress of their team; and manages numerous mergers, acquisitions, and financings. It also helps lawyers and legal teams to categorize, review, and analyze various documents and contracts in the data room. Emily Foges founded founded Luminance in 2015. It has its headquarters in Cambridge in the United Kingdom.
- Beyond — Write your will online, apply for probate or arrange a meaningful funeral.
- Clausematch — Our award-winning policy management, regulatory change management and compliance platform automates time-sucking tasks, organises your data and makes collaboration and knowledge-sharing a breeze. Learn more here
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Spain, United States, Switzerland
Investor stats
- Total investments: 78
- Round size: Series A $2.2M–$63M; Series B $17M–$135M; Series C $27M–$80M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Prexton Therapeutics — Voici la page d'accueil du site web
CDTI Innovación's INNVIERTE program is part of the Spanish Science, Technology, and Innovation Strategy. This Strategy is one of the cornerstones around which the Government's R&D&I strategy for the upcoming years is built. It outlines the goals, changes, and actions that must be implemented across the R&D&I sector inorder to maximize its growth and effect.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: Spain, Switzerland
Investor stats
- Total investments: 21
- Round size: Seed $526k–$4.2M; Venture - Series Unknown $761k–$1M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
- LuxQuanta — Quantum Key Distribution or Quantum Cryptography provides long-term and future-proof data protection.
- Zoundream — The Future of Infant Care
Charme Capital Partners is a European mid-market private equity fund, supporting management teams and shareholders to achieve transformational change, growth and internationalisationFrom our offices in Milan, London and Madrid we invest in businesses across Europe with an enterprise value of €100m to €500mContinuous interaction with ourinvestor base is key in sourcing new opportunities, testing investment theses and growing portfolio companies
Show more...Investment focus
- Industry: Genetics, Life Science, Biotechnology
- Stage:Series A
- Geography: Spain
Investor stats
- Total investments: 3
- Round size: Series A $5.5M–$20M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Bianalisi — Bianalisi provides services that include toxicological examination of the hair, diagnostic imaging, specialised examinations, laboratory analysis, physiotherapy and rehabilitation, occupational medicine, and more. They offer diagnostic services.
- Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.
Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Seed to Series B) managing more than €300M of AUM.
Show more...Investment focus
- Industry: Software, Biotechnology, E-Commerce
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 150
- Round size: Seed $256k–$3.8M; Series A $1.9M–$21M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- Scalestack — Scalestack AI brings all of your GTM data together, suggests prioritized actions and helps your reps to execute your sales plays. Unlock a new level of sales productivity and generate more pipeline.
- iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.
Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Series A, Seed
- Geography: Spain, United States
Investor stats
- Total investments: 16
- Round size: Series A $3M–$33M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Mediktor — Mediktor is an interactive tool that can analyse users' symptoms and evaluate their state of health. It also allows them to chat with a doctor in real time.
Clave is an investment management company.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: Spain, Chile, Switzerland
Investor stats
- Total investments: 37
- Round size: Seed $527k–$4M; Series A $4.9M–$16M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $53M in 2023
Portfolio highlights
- Innitius — AI-powered obstetric diagnostics for improved preterm birth risk assessment.
- homedoctor — Homedoctor is an online medical care app that offers medical video consultations. With Homedoctor's health robot, users can keep an eye on their own vital signs and record the information in their medical records to look for abnormalities in their internal and external organs. Specialists from Homedoctor's team in pediatrics, gynecology,internal medicine, dermatology, psychiatry, pneumonia, sports, and rehabilitation medicine, and nutrition help patients in a live video consultation while relying on the tools to provide an accurate diagnosis.
- D-Sight — D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population.
BeAble Capital is a Science Equity Fund, therefore it is a pre-seed, seed and early stage venture capital management company specialized in the identification, valuation, launch and development of technologies in the sectors of advanced materials (nanotechnology and biotechnology), photonics, micro and nano electronics and Information andcommunications technologies (ICT) platforms.It acts as the link between scientific, entrepreneurial and investing worlds to promote the transfer of technology, the creation and the development of technology-based companies (start-ups) from private equity. The company is focused on strong intelectual property and long R&D background projects. Their work provide value at different stages of development by offering support in strategic points such as the identification of technologies, valuation, transfer, companies creation, fundraising, marketing, internationalization and administrative and managerial expertise.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Software
- Stage:Pre-Seed, Seed
- Geography: Spain, Italy
Investor stats
- Total investments: 63
- Round size: Seed $154k–$1.2M; Pre-Seed $124k–$207k
- Lead/follow: 84% lead, 16% follow
- Last fund: May invest from a new fund soon — raised $37M in 2016
Portfolio highlights
- Reinforce 3D — Reinforce3D develops proprietary technology for reinforcing 3D-printed parts, called the continuous fiber injection process (CFIP)
- Molecular Gate — Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs target the secretory translocon (Sec61 channel) in cells to selectively block and degrade harmful extracellular proteins before they can be secreted and cause disease.
- Bioinspired Materials — Bioinspired Materials is a Biotech-based entrepreneurship project with the participation of the Universitat Pompeu Fabra. The company develops wastewater valorization that produces biological products of high value in the market. BIOM was founded in 2019 and is based in Barcelona, Spain.
As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Medical
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 8
- Round size: Seed $2M–$7.4M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Aortyx — With a focus on aortic dissection, Aortyx has developed a bioresorbable endovascular patch designed to seal the entry tear, delivered through a proprietary dual-steerable catheter.
- Heecap — Heecap is a non-invasive, tailored electrostimulation technology that maintains respiratory muscle strength in these patients.
- Gyala Therapeutics — Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas.
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 40
- Round size: Seed $2.4M–$15M; Pre-Seed $125k–$7.8M; Series A $12M–$26M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Lindus — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
- Nostos Genomics — Our genetic variant interpretation platform enables genetic testing labs to give more people with genetic diseases a clear and fast diagnosis.
- Kernal Biologics — Kernal biologics is an onco-selective mRNA therapeutics company located in Cambridge, MA
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 2
- Round size: Seed $3.4M–$7.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies
Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic
Show more...Investment focus
- Industry: Software, FinTech, Health Care
- Stage:Pre-Seed, Seed, Series A
- Geography: Spain, Portugal, Poland
Investor stats
- Total investments: 81
- Round size: Seed $110k–$3.1M; Pre-Seed $110k–$329k
- Lead/follow: 62% lead, 38% follow
- Last fund: May invest from a new fund soon — raised $52M in 2020
Portfolio highlights
- Qalea —
- Dealcar — DEALCAR is a company that digitalizes the used car market through a SaaS platform, enabling fully digital transactions. This platform creates a network effect benefiting dealers, partners, and customers. • Dealers: Increase revenue by selling extra products and boost sales by reducing turnover time. • Partners: Distribute products at the pointof sale without marketing expenses, lowering operational costs. • Consumers: Purchase a used car easily in just three steps, enjoying a smooth, trusted process similar to renting but with the benefits of owning a car.
- KomboAI — Supercharge your CRM and close more deals with KomboAI Find the right leads, engage them with purpose and improve your skills every day. Book a Demo See Kombo in Action Over 1000+ sales reps are already using KomboAI during their job Join the sales revolution today Find the right leads Receive every day new leads
A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success. - Investment and growth - Specialized products and branches - Collaborative innovation
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Spain, Mexico, United States
Investor stats
- Total investments: 81
- Round size: Seed $110k–$2.2M; Pre-Seed $110k–$2.2M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- TietAI — TietAI builds healthcare data interoperability infrastructure for hospitals, research networks and life sciences. The platform, Hydra, is split into two products. Hydra Connects is non-medical-device middleware for clinical data exchange across HL7v2, FHIR, DICOM, OMOP, X12 and CDA. Hydra Agentic is a high-risk AI system under the EU AI Act,designed for clinical agentic workflows.
- Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
- xNova International — Find US importers with the xNova International platform in seconds. Monitor your competitors, analyze your product's demand in the US, and much more.
Speedinvest is a globally active European venture capital firm built on a simple belief: many move more. From six offices across EMEA, our sector-focused investment teams back relentless founders from pre–Seed to Growth with long-term conviction, providing day-one access to our global network of corporate customers, experts, industry leaders, andtop-tier follow-on investors to scale smarter and faster. Building lasting companies like Bitpanda (Austria), Moove (Nigeria), Gigs (U.S.), Tide (UK), ARX Robotics (Germany), Wayflyer (Ireland), GoStudent (Austria), Seqera Labs (Spain), and Cylib (Germany) — together. Big ideas may start with one. But scaling and winning take The Power of More.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, Austria
Investor stats
- Total investments: 518
- Round size: Seed $823k–$8M; Pre-Seed $406k–$3.8M; Series A $3.7M–$38M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $384M in 2022
Portfolio highlights
- Findery — Find and leave notes anywhere in the world, discover local knowledge, hidden secrets, and exciting stories. Share your travel knowledge, geoblog, or local news!
- MinersAI — Unlock valuable insights from intricate geological data with Miners AI. Our AI-driven platform empowers exploration teams to make informed decisions and optimize mining operations.
- Primer — Primer is the first open automation platform for payments, enabling you to build end-to-end payment flows with no code, and a checkout developers love.
BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 64
- Round size: Seed $1.1M–$8.7M; Pre-Seed $274k–$2M; Series A $717k–$41M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- DrugBank — DrugBank augments human intelligence to improve the world’s health. Our suite of products are powered by the world’s most complete and up-to-date pharmaceutical knowledge database. It includes everything there is to know about drugs and how they work in the body. We enable companies to improve healthcare delivery through precision medicine orclinical software applications, as well as uncover insights through data science in drug discovery. Our knowledge base can be integrated into software solutions to help achieve clinical intelligence. Companies can easily scale their usage through our API and launch faster with flexible data modules. By providing users with advanced insights and the right information at the right time, users are empowered to make better health decisions.Our extensive, structured datasets are used to discover novel drug candidates, identify drug repurposing opportunities, and build predictive machine learning models. Companies working with data science can find answers quickly and get drugs to market faster with our evidence-based drug information. Lastly, our publicly available resource, DrugBank Online, is free-to-use with limited datasets available for download for academic and non-commercial researchers. DrugBank has been cited in over 13,000 academic publications and is used by millions of researchers and health professionals globally.
- Axonis Therapeutics — AXONIS Therapeutics, Inc. is advancing breakthrough discoveries to develop first-in-class therapies for neurological disorders.
- Vivid Machines — Digitizing permanent crop production | Vivid Machines | Ontario
Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Israel, United States
Investor stats
- Total investments: 31
- Round size: Seed $25k–$7M; Series A $6.7M–$21M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
- Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 106
- Round size: Series A $4M–$95M; Series B $20M–$100M; Series C $12M–$104M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series C, Series A
- Geography: United States, The Netherlands, Germany
Investor stats
- Total investments: 124
- Round size: Series A $8.8M–$63M; Series B $15M–$120M; Series C $21M–$75M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $786M in 2023
Portfolio highlights
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
- Endovascular Engineering — Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications.
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 128
- Round size: Seed $2.3M–$13M; Series A $3.8M–$74M; Series B $8.8M–$80M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- Vico Therapeutics — Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea
- Synendos Therapeutics — Synendos Therapeutics is a biopharmaceutical company that aims to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of natural functioning of the brain.
Clave Mayor is a management company of closed investment entities based in Navarra.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Spain, Germany, United States
Investor stats
- Total investments: 33
- Round size: Seed $262k–$5.5M; Series A $2.2M–$8.9M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
- Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
- Semi Zabala — Welcome to Semi Zabala, a pioneering semiconductor company dedicated to innovation and excellence. Our mission is to push boundaries and enhance technology, embodying our slogan: beyond the power. Explore our advanced solutions designed for a smarter, more connected future.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Our purpose is to help people and businesses prosper. We strive to make all we do Simple, Personal and Fair.
Show more...Investment focus
- Industry: Energy, Financial Services, Renewable Energy
- Stage:Debt Financing, Post-IPO Debt, Seed
- Geography: United Kingdom, Spain, United States
Investor stats
- Total investments: 91
- Lead/follow: no public data
Portfolio highlights
- Klar — Klar is a FinTech challenger bank that provides deposit and credit services for Mexican customers.Using the Klar card rewards users with cash of up to 4% cashback for each purchase, not points without confusing conversions or expiration dates. Clients can also send and receive payments and collections money instantly to Klar accounts and otherbanks. The Klar card is linked to an app where users can see all their movements in real-time.Stefan Moller, Daniel Autrique, Jeronimo Riefkohl, and Gianluigi Davassi established the company in Mexico City, Distrito Federal in 2018.
- ARAUCO — ARAUCO is a diversified global company in the forestry industry. They use world-class technologies and processes throughout the value chain. They are present in the forestry, pulp, timber, panels and renewable energy businesses.
- NORNORM — High quality pre-loved office furniture, including office design, installation and flexibility to change. Own less, pay less, and change whenever.
Alantra is an international financial services firm with over 500 professionals across EMEA, the Americas, and Asia.
Show more...Investment focus
- Industry: Financial Services, Manufacturing, Information Technology
- Stage:Private Equity, Debt Financing, Series B
- Geography: Spain, France, Sweden
Investor stats
- Total investments: 27
- Lead/follow: no public data
Portfolio highlights
- enmacc — enmacc, the OTC energy trading platform, offers innovative solutions for efficient trading of energy commodities in today's dynamic market.
- SunRoof — Roof of the future
- Eturnity AG — Die Eturnity Software automatisiert den und erleichtert den Beratungs- und Verkaufsprozess im Bereich der Erneuerbaren Energiesysteme.
Ship2B Ventures is a venture capital firm that invests in impact startups.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Agriculture
- Stage:Seed, Series A
- Geography: Spain, Germany, United Kingdom
Investor stats
- Total investments: 20
- Lead/follow: no public data
Portfolio highlights
- Aortyx — Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cellmigration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
- Nido — Heating & cooling accounts for nearly half of all energy consumption and 40% of energy-related carbon dioxide emissions. In the EU 65M+ boilers are over their useful life and 95% of them use fossil fuels and these need urgent change.At Nido, we are streamlining heat pump installation in the residential sector, enabling users to transition toclean heating & cooling faster with affordable pricing. We also support installers get the best out of their time by removing time consuming tasks and allowing them to focus on their preferred task - home installations!
- Ocean Ecostructures — We convert maritime infrastructures into 'nature positive' spaces through our multi-technological solution.
General Inception partners with inventors to ignite innovation and create transformational companies. We are co-founders bringing together domain expertise, seasoned executive talent, infrastructure resources, and capital to nurture company growth from inception.
Show more...Investment focus
- Industry: Biotechnology, Life Science, Genetics
- Stage:Seed, Pre-Seed
- Geography: United States, Spain, France
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Biocellis — Biocellis develops ultra-sensitive, bioluminescence-based diagnostics for next-generation immunoassays. Scalable, fast, and point-of-care ready.
- Pharmacelera — Improving pharmaceutical R+D productivity through a lean drug discovery process based on advanced computational methodologies.
- Tavira Therapeutics — Tavira Therapeutics develops an innovative technology that equips AAV vectors with molecules to accurately target the intended tissues.
I am a food scientist, entrepreneur and investor. Through SFV (sustainablefoodventures.com), I back founders building the future of cell-based, plant-based and recombinant food.
Show more...Investment focus
- Industry: Food Processing, Seafood, Wellness
- Stage:Pre-Seed, Angel
- Geography: Spain, Iceland, United States
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Loki Foods — We're producing sustainable, plant-based foods from the Arctic. Iceland’s first plant-based cod and seafood!
- Sobo Foods — Sobo Foods is a plant based comfort food provider.
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Biotechnology
- Stage:Pre-Seed, Seed
- Geography: Spain
Investor stats
- Total investments: 15
- Lead/follow: no public data
Portfolio highlights
- Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
- SHINEPHI — Shinephi's vision is to change the state-of-the-art in nano-characterization and nano-fabrication to improve yield and expedite production in semiconductor manufacturing.
- Virtest Technologies — Virtest Technologies is an innovation firm focused on personalized medicine, providing computational models, simulations, and image processing solutions to aid surgeons and medical device companies in testing products, enhancing decision-making, and improving clinical outcomes.
Innova-Tech Consulting provides independent specialist Audio Visual and Technology consulting services.
Show more...Investment focus
- Industry: Solar, Energy, Medical
- Stage:Series A, Seed, Series B
- Geography: Canada, Spain
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- SiXtron Advanced Materials — Founded in 2004, SiXtron is a private, venture backed company located in Montreal, Quebec, focusing on developing anti-reflective coating solutions for the solar cell industry.Other highly scalable and cost-effective thin film coating solutions, for both the electronics industry and the industrial coatings sector, are under development. Sixtronthin films have unique optical and mechanical properties, and can be deposited without the complex requirements of hazardous silane gas.
- Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
- Optosecurity — PAX CHECKPOINT combines automated screening lanes with a screening software to create a fully integrated checkpoint solution.
BCNPeptides is dedicated to pioneering R&D in cutting-edge bioactive peptides. We deliver tailor-made, high-quality solutions
Show more...Investment focus
- Industry: Medical, Biopharma, Life Science
- Geography: Spain
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.
Show more...Investment focus
- Industry: Financial Services, FinTech, E-Commerce
- Stage:Seed, Angel, Pre-Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 25
- Lead/follow: no public data
Portfolio highlights
- Ukio — Artfully designed fully furnished apartments available for extended stays
- Paack — Find the ideal delivery solution to integrate into your e-commerce. We adapt to your business, providing your customers with an amazing experience.
- Openlytics — Openlytics is a visual analytics platform. It allows Data Workers to create pipelines for data transformation and analysis, in a visual way. Our mission is to empower everyone in the organization to solve data problems, without waiting for developers.Openlytics is an early-stage company, looking to build a founding team that can shape thedirection of the product. We’re seed-funded, remote-first, and hiring.If you're interested in learning more, email us at hello@openlytics.io.
Fides Capital is an investment firm, specialized in seed and early stage technology-based companies with scalable B2B business models that have already achieved recurring income. We back committed and experienced teams who are capable of leading ambitious projects with international projection. But, beyond the professional abilities, for usit's essential to have a personal understanding and alignment of interests with the entrepeneurs in order to row together in the same direction. Partnering with the teams is a key pillar in Fides's investment strategy since we like to collaborate actively with them, sharing our experience and knowledge. We invest between 50,000 € and 400,000 € per deal by disbursing funds in gradual installments and we co-invest with other participants that assume the role of lead investor.Our portfolio companies are mainly in the telecom, B2B services, health, fintech and edutech sectors: - AdmInMe (www.admin-me.com) - Agile Content (www.agilecontent.com) - eGarante: (www.egarante.com) - Excom (www.excom.es) - Imegen (www.imegen.es) - Indexa Capital (www.indexacapital.com) - Joinup (www.joinuptaxi.com) - Kuaderno (www.kuaderno.com) - Masmovil (www.masmovil.es) - Next (www.gruponext.es) - Nuubo (www.nuubo.com) - Playfilm (www.playfilm.tv) - Quantyca (www.quantyca.com)
Show more...Investment focus
- Industry: Software, Automotive, Telecommunications
- Stage:Seed, Pre-Seed, Series A
- Geography: Spain
Investor stats
- Total investments: 23
- Lead/follow: no public data
Portfolio highlights
- Lawwwing — Lawwwing provides a distinctive solution in the market for website compliance. It's a platform that automatically adapts your website or online store to regulations, keeping it up-to-date and personalized.
- Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
- CHECKTOBUILD — Compare automatically the reality of your construction inspection with the BIM Model and get an accurate as-built analysis.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Ezten Venture Capital Fund
Show more...Investment focus
- Industry: Software, Automotive, Clean Energy
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- EPowerlabs — EPowerlabs offers electric mobility components both in passenger car and heavy duty segments to help OEM and Tier 1 build electric cars
- Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
- Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
CDTI
Show more...Investment focus
- Industry: Apps, Big Data, Aerospace
- Stage:Pre-Seed, Series A
- Geography: Spain
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- Inspide — Understand all the information in the real world and make it actionable
- FYLA — At FYLA we create unique All-fiber Ultrafast pulsed lasers by Joining Singularity with Quality. Discover our multiphoton and two photon lasers!
- 2Eyes Vision — 2EyesVision is a start-up (CSIC spin-off) specialized in the creation, development, and commercialization of novel ophthalmic technologies.
Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Series C
- Geography: United States, Switzerland, United Kingdom
Investor stats
- Total investments: 209
- Round size: Series A $4.7M–$81M; Series B $11M–$105M; Series C $9M–$75M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $200M in 2009
Portfolio highlights
- Rhygaze — Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.
- Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
- Amphista Therapeutics — We are purposefully designing the next generation of targeted protein degraders to transform the lives of patients with intractable diseases.
Originally studying medicine in Scotland, John is a pioneer of the Australasian medical recruitment industry and has over 20 years of experience growing his award-winning business, Wavelength International, from two founders to over 100 staff. Moving to Europe in 2012, John worked initially for an equity crowdfunding business focused on raisingseed funds for European life sciences start-ups, before launching the Luka Global Group, including LUKA BIO, with the co-founders in 2019. John provides guidance and mentorship to start-up founders on how to set up their own in-house recruitment capabilities in preparation for growth. His recruitment portfolio includes C-suite, medical and research roles within life sciences.
Show more...Investment focus
- Industry: FinTech, Medical, Life Science
- Stage:Debt Financing
- Geography: Spain
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Capital Cell — Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
We invest in early & growth stage technology companies. We were founded with a mission to support visionaries in building impactful & enduring businesses.
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Brazil
Investor stats
- Total investments: 143
- Lead/follow: no public data
Portfolio highlights
- Tines — Tines is an enterprise automation platform designed to help security and ops teams automate manual workloads. With 1,000+ template options for common security actions, Tines is power and simplicity through direct integration with your existing tools. The company was founded in 2018 and is headquartered in Dublin.
- Hello Vet — Same-day vet appointments, emergency care & calm clinics across London. Find trusted veterinary care with Hello Vet.
- Modern Animal — Modern Animal is an innovative veterinary platform building a new kind of veterinary experience for animals and humans. The veterinary platform offers unlimited exams, in-app prescription requests & delivery, 24/7 virtual care, and more. They build innovations in technology and design give you greater access to a team of experts,flexibility, and convenience in every interaction, and the highest level of personalized care.Modern Animal built the next generation in veterinary care, reshaping a traditional industry to better meet the needs of pet owners, pets, practitioners and staff. Through the state-of-the-art app and in-clinic technology and design, as well as a membership model that allows for quality relationships to develop between doctors, pets and pet owners.Modern Animal was founded in 2019 and is headquartered in Los Angeles, California, USA.
Life sciences R&D, consulting and investment
Show more...Investment focus
- Industry: Medical, Pharmaceutical, Biopharma
- Stage:Seed, Pre-Seed
- Geography: Spain
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Thytech — Thytech is a health tech company.
- Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
- Ownmed Innovation — Ownmed Innovation is a Medtech spin-off that emerged from the collaboration between the Fundación para la Investigación Biomédica Hospital Gregorio Marañón (FIBHGM), the Instituto Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD) and Universidad Carlos III de Madrid (UC3M). Its main objective is the development of a medical device, Ostofix®,aimed at ostomate patients, with the purpose of restoring their ability to regain control over their continence.
All-in-one solution for fundraising, managing and trading equity. Explore promising tech startups and flexible funding opportunities with SeedBlink.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Romania, United States, United Kingdom
Investor stats
- Total investments: 103
- Lead/follow: no public data
Portfolio highlights
- Pago — Managing and paying utility bills, insurance, mobile top-ups and taxes takes too much time for many households in Europe. Pago simplifies these payments by adding automation where possible, using integrations with billers, insurers and online platforms to dramatically reduce the time needed for all these payments. The service is available in theB2C app called Pago and through B2B integrations by embedding Pago features in partner apps through SDK or API. Pago's services are used by over 500k monthly active users in Romania, Poland and Italy.
- Brainactive — Brainactive is an AI-driven platform that streamlines the access to vital insights used by companies to make sound business decisions, by enabling them to directly interview their current and potential customers, regardless of their expertize in sociology, past experience with market research, size of their team, or their market research budget.Integrated with a pool of 300+ million vetted and engaged consumers around the world, the platform allows companies to get relevant answers to their questions in minutes, with assistance from advanced conversational and generative LLM trained on market research, available along the way.Putting businesses in direct contact with their customers essentially removes the need for any intermediaries in the process and brings the costs and time down to a mere fraction of what traditional market research typically requires. At the same time, companies get to keep sensitive concepts and prototypes tested entirely secured, since no one else is involved, at any stage.
- dotLumen - Empowering the Blind — .lumen builds glasses that help the blind live a better life.
ICF Capital is a venture and growth capital management firm from ICF. ICF is a public financial institution founded in 1985 and owned by the Government of Catalonia. Our mission is to foster and improve access to funding for companies that operate in Catalonia in order to contribute to the growth of the region's economy while complementing theprivate financial sector. ICF provides funding to Catalan companies and entrepreneurs. They assist them in their development and growth, generating value for society at large. The institution offers companies a range of products and services in the area of corporate finance, focusing on loans and guarantees and venture capital investments. ICF operates via a parent company, two subsidiaries (IFEM and ICF Capital), and an investee (AVALIS). ICF, through IFEM, supports the creation and growth of innovative start-ups through the investment in venture capital funds for seed segments and co-investment with private investors through participative loans. ICF Capital, which manages closed-end UCITS and is authorized by Spain's National Securities Market Commission (CNMV), manages, nurtures, and advises public and/or private funds or venture capital firms that provide capital to Catalan companies. At present, ICF Capital directly manages 2 venture capital firms: ICF Capital Expansió II and ICF Venture Tech II.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Debt Financing, Seed
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 98
- Lead/follow: no public data
Portfolio highlights
- Exoticca — Exoticca develops an online platform intended to facilitate travel booking. The company's platform offers holiday packages which includes flights, accommodation, meals, guides and private transports, for exotic locations all around the world, enabling travelers to book travel packages online at competitive prices.
- Harmonix — Harmonix is a software development company that uses AI for CRM to communicate with customers to send email, calls, and SMS.
- AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.
CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Seed
- Geography: Spain, Mexico
Investor stats
- Total investments: 13
- Round size: Seed $3.3M–$5.3M; Series A $2.2M–$8.9M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $70M in 2010
Portfolio highlights
- Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
- Biocross — Biocross, S.L., a biotechnology company, develops blood tests for the diagnosis of Alzheimer’s diseases to neurologists.
- Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
BAGi is the first business angels network created for invest on Startups with direct impact on Girona's region.
Show more...Investment focus
- Industry: Internet, Health Care, Information Technology
- Stage:Seed, Angel
- Geography: Spain, Norway, Switzerland
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- Aniling — Aniling developing its worldwide patent of the second generation genomic analysis and epigenomic.
- Petoons Studio — Petoons Studio is a developer of transmedia projects startup.
- The Smart Lollipop — The Smart Lollipop is a non-intrusive medical device in the shape of a lollipop with the goal to detect diseases with a single saliva sample.
Life Science Investor funding in Spain at a glance
Stats across 102 deals from 130 investors.
Access all 130 investors in Spain Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Investors in Spain investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 130 investors investing in Spain Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!